TESARO’s Niraparib Significantly Improved Progression-Free Survival

June 29, 2016 7:03 pm

TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced that the Phase 3 NOVA trial of niraparib successfully achieved its primary endpoint of progression-free survival (PFS). This trial demonstrated that niraparib significantly prolonged PFS compared to control among patients who … Read more

Resilience: A Necessary Ingredient in Overcoming Cancer

June 23, 2016 11:26 pm

By: Annette McElhiney

“Resilience presents a challenge for psychologists. Whether you can be said to have it or not largely depends not on any particular psychological test but on the way your life unfolds. If you are lucky enough to Read more

Biden: Moonshot Requires ‘Open Collaboration, Open Minds’

June 14, 2016 5:56 pm

Increased collaboration and a willingness to see beyond the expected will be critical to the success of the national cancer moonshot initiative, Vice President Joe Biden told ASCO Annual Meeting attendees this afternoon. “No single oncologist or cancer researcher can … Read more

Precision Medicine and Cancer

June 8, 2016 7:16 pm

ASCO’s (American Society of Clinical Oncology) Annual Meeting was held on June 2nd through June 7th in Chicago, Illinois. ASCO offers premier scientific events for oncology professionals, patients, patient advocates, industry representatives, and major media outlets worldwide. It showcased new … Read more

Combination Of Chemotherapy And Immunotherapy May Be Effective

June 8, 2016 7:04 pm

Inside each ovarian tumor, there are good cells and bad cells. A new paper explains their roles: The bad cells are fibroblasts. They work to block chemotherapy, which is why nearly every woman with ovarian cancer becomes resistant to treatment. … Read more

New Trends Could Increase Ovarian Cancer Survival Rates!

June 7, 2016 5:46 pm

By: Annette McElhiney

I’ve mentioned frequently, I’m not a medical doctor or a scientific researcher. I’m simply a former nurse, retired college English and Womens Studies Professor, and an 8-year survivor of IIIC ovarian cancer who wants to improve my … Read more

Precision Medicine Yields Better Outcomes for Clinical Trial Patients

June 2, 2016 6:21 pm

A meta-analysis of 346 phase I clinical trials involving more than 13,000 patients found that patients whose treatment was selected based on the molecular characteristics of their tumor had significantly better outcomes. The study was featured in a press briefing … Read more

8 Things Every Woman Needs To Know About Ovarian Cancer

May 17, 2016 6:32 pm

“Ovarian cancer is the most feared gynecologic cancer,” says Teresa Diaz-Montes, MD, associate director of the Lya Segall Ovarian Cancer Institute at Mercy Medical Center in Baltimore, MD. Perhaps that’s for good reason: Often called the “silent killer,” the disease … Read more

Ovarian Cancer and Talc: Did Junk Science Cost Johnson & Johnson?

May 11, 2016 6:08 pm

Johnson & Johnson is an immense pharmaceutical and consumer products company of the type that the public loves to hate. Recently, it’s been getting absolutely killed by juries holding its baby powder responsible for causing several women’s ovarian cancers. The … Read more

Marijuana Benefits, Risks For Patients With Cancer Need More Study

May 9, 2016 8:13 pm

Even as an increasing number of states approve the use of medical marijuana, a review of medical literature and existing data finds that huge questions remain about its true benefits and risks for patients with cancer.Investigators found that … Read more

Scalp Cooling Safe, Long-term European Data Show

May 4, 2016 6:31 pm

For cancer patients undergoing alopecia-inducing chemotherapy, scalp cooling to reduce hair loss is safe, according to new research. “This is a treatment that women going into chemotherapy treatment need to know about,” said Mikel Ross, RN, BSN, from the Memorial … Read more

Profile-Matched Patient Assistance and Clinical Trial Options

May 2, 2016 8:38 pm

Clearity has taken steps to help accelerate molecular matching by enabling women to access the drugs their physicians prescribe to treat their ovarian cancer. The pilot Clearity Match Patient Assistance program that was recently announced helps subsidize the cost of … Read more

Clearity’s Precision Medicine Symposium Demonstrates Sea Change in Personalized Ovarian Cancer Treatment

May 2, 2016 8:38 pm

By: Cory Bentley, PhD

The Society for Gynecological Oncology (SGO) Meeting this March in San Diego brought together physicians and scientists from all over the world to share the latest research, treatments, and thinking in gynecological cancers including ovarian. Clearity … Read more